Published in Rev Med Suisse on November 16, 2005
Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases. Eur J Clin Pharmacol (2011) 1.43
Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines. Lancet (2009) 4.07
Etiology of community-acquired pneumonia in hospitalized children based on WHO clinical guidelines. Eur J Pediatr (2009) 2.80
Impact of different backup respiratory rates on the efficacy of noninvasive positive pressure ventilation in obesity hypoventilation syndrome: a randomized trial. Chest (2013) 2.68
APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells. Blood (2008) 2.44
Revisiting human IL-12Rβ1 deficiency: a survey of 141 patients from 30 countries. Medicine (Baltimore) (2010) 2.33
Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor beta1 deficiency: medical and immunological implications. J Exp Med (2003) 2.19
Challenges in infant immunity: implications for responses to infection and vaccines. Nat Immunol (2011) 2.17
Polysomnography in stable COPD under non-invasive ventilation to reduce patient-ventilator asynchrony and morning breathlessness. Sleep Breath (2011) 2.13
Influence of Mycobacterium bovis bacillus Calmette-Guérin on antibody and cytokine responses to human neonatal vaccination. J Immunol (2002) 1.98
TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts. Blood (2007) 1.85
Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants. J Pediatr (2007) 1.77
Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study. Arthritis Rheum (2011) 1.67
Synchronization of dendritic cell activation and antigen exposure is required for the induction of Th1/Th17 responses. J Immunol (2012) 1.59
Ascites and highly elevated CA-125 levels in a case of peritoneal tuberculosis. Scand J Infect Dis (2006) 1.52
Monitoring of noninvasive ventilation by built-in software of home bilevel ventilators: a bench study. Chest (2011) 1.51
Can successful vaccines teach us how to induce efficient protective immune responses? Nat Med (2005) 1.48
Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity. Nat Med (2010) 1.45
Aluminum hydroxide adjuvant induces macrophage differentiation towards a specialized antigen-presenting cell type. Vaccine (2004) 1.36
Impaired antibody response causes persistence of prototypic T cell-contained virus. PLoS Biol (2009) 1.31
Nasopharyngeal carriage of Streptococcus pneumoniae shortly before vaccination with a pneumococcal conjugate vaccine causes serotype-specific hyporesponsiveness in early infancy. J Infect Dis (2010) 1.27
Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody. Clin Infect Dis (2008) 1.26
Rapid eye movement-related disordered breathing: clinical and polysomnographic features. Chest (2005) 1.25
Risk assessment of tuberculosis in immunocompromised patients. A TBNET study. Am J Respir Crit Care Med (2014) 1.22
Knowledge of guidelines for the management of COPD: a survey of primary care physicians. Respir Med (2004) 1.22
Upper-respiratory viral infection, biomarkers, and COPD exacerbations. Chest (2010) 1.18
Performance characteristics of 10 home mechanical ventilators in pressure-support mode: a comparative bench study. Chest (2005) 1.16
A global perspective on vaccine safety and public health: the Global Advisory Committee on Vaccine Safety. Am J Public Health (2004) 1.15
How do physicians immunize their own children? Differences among pediatricians and nonpediatricians. Pediatrics (2005) 1.13
Reduced ability of neonatal and early-life bone marrow stromal cells to support plasmablast survival. J Immunol (2006) 1.12
Effect of month of vaccine administration on antibody responses in The Gambia and Pakistan. Trop Med Int Health (2006) 1.11
Mycobacterium tuberculosis transmission in a country with low tuberculosis incidence: role of immigration and HIV infection. J Clin Microbiol (2011) 1.10
Use of pneumococcal polysaccharide vaccine in children: what is the evidence? Curr Opin Infect Dis (2012) 1.09
Adult-like anti-mycobacterial T cell and in vivo dendritic cell responses following neonatal immunization with Ag85B-ESAT-6 in the IC31 adjuvant. PLoS One (2008) 1.08
Walking activity measured by accelerometry during respiratory rehabilitation. J Cardiopulm Rehabil (2003) 1.08
Chronic hypoxia: common traits between chronic obstructive pulmonary disease and altitude. Curr Opin Clin Nutr Metab Care (2004) 1.08
Glycoconjugate vaccines and immune interference: A review. Vaccine (2010) 1.07
Acceptability of maternal immunization against influenza: the critical role of obstetricians. J Matern Fetal Neonatal Med (2012) 1.06
Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients. Nephrol Dial Transplant (2009) 1.06
Immunogenicity and protective efficacy of neonatal vaccination against Bordetella pertussis in a murine model: evidence for early control of pertussis. Infect Immun (2002) 1.05
Vaccination during pregnancy to protect infants against influenza: why and why not? Vaccine (2011) 1.05
HIV infection disrupts the sympatric host-pathogen relationship in human tuberculosis. PLoS Genet (2013) 1.04
Predominant influence of environmental determinants on the persistence and avidity maturation of antibody responses to vaccines in infants. J Infect Dis (2006) 1.04
Vaccine effectiveness in older individuals: what has been learned from the influenza-vaccine experience. Ageing Res Rev (2010) 1.03
Booster vaccination after neonatal priming with acellular pertussis vaccine. J Pediatr (2010) 1.02
Inhibition of B cell death causes the development of an IgA nephropathy in (New Zealand white x C57BL/6)F(1)-bcl-2 transgenic mice. J Immunol (2004) 1.00
Intranasal immunization with pneumococcal conjugate vaccines with LT-K63, a nontoxic mutant of heat-Labile enterotoxin, as adjuvant rapidly induces protective immunity against lethal pneumococcal infections in neonatal mice. Infect Immun (2002) 0.99
Environmental and T cell-intrinsic factors limit the expansion of neonatal follicular T helper cells but may be circumvented by specific adjuvants. J Immunol (2012) 0.99
A cationic vaccine adjuvant based on a saturated quaternary ammonium lipid have different in vivo distribution kinetics and display a distinct CD4 T cell-inducing capacity compared to its unsaturated analog. J Control Release (2012) 0.98
The next decade of vaccines: societal and scientific challenges. Lancet (2011) 0.97
A liposome-based mycobacterial vaccine induces potent adult and neonatal multifunctional T cells through the exquisite targeting of dendritic cells. PLoS One (2009) 0.96
Contact tracing for tuberculosis and treatment for latent infection in a low incidence country. Swiss Med Wkly (2008) 0.96
Clinical presentation, demographics and outcome of tuberculosis (TB) in a low incidence area: a 4-year study in Geneva, Switzerland. BMC Infect Dis (2009) 0.96
Dominant-negative tumor necrosis factor protects from Mycobacterium bovis Bacillus Calmette Guérin (BCG) and endotoxin-induced liver injury without compromising host immunity to BCG and Mycobacterium tuberculosis. J Infect Dis (2009) 0.95
Homing and adhesion patterns determine the cellular composition of the bone marrow plasma cell niche. J Immunol (2012) 0.95
Protective anti-mycobacterial T cell responses through exquisite in vivo activation of vaccine-targeted dendritic cells. Eur J Immunol (2008) 0.95
Frequent failure of adolescent booster responses to tetanus toxoid despite infant immunization: waning of infancy-induced immune memory? Vaccine (2010) 0.95
Response to treatment and disease progression linked to CD4+ T cell surface CC chemokine receptor 5 density in human immunodeficiency virus type 1 vertical infection. J Infect Dis (2002) 0.95
Neonatal immunization: where do we stand? Curr Opin Infect Dis (2011) 0.95
Influenza vaccination given at least 2 weeks before delivery to pregnant women facilitates transmission of seroprotective influenza-specific antibodies to the newborn. Pediatr Infect Dis J (2013) 0.93
Do results of the T-SPOT.TB interferon-gamma release assay change after treatment of tuberculosis? Respir Med (2008) 0.93
Tuberculosis in HIV-negative and HIV-infected patients in a low-incidence country: clinical characteristics and treatment outcomes. PLoS One (2012) 0.91
Mode of action of adjuvants: implications for vaccine safety and design. Biologicals (2010) 0.89
Vaccine safety controversies and the future of vaccination programs. Pediatr Infect Dis J (2005) 0.89
The advantage of mucosal immunization for polysaccharide-specific memory responses in early life. Eur J Immunol (2005) 0.89
Antibody responses to natural influenza A/H1N1/09 disease or following immunization with adjuvanted vaccines, in immunocompetent and immunocompromised children. Vaccine (2011) 0.89
CD4-independent protective cytotoxic T cells induced in early life by a non-replicative delivery system based on virus-like particles. Virology (2003) 0.88
ABCB1 polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemia. Pharmacogenomics (2011) 0.87
Effect of a comprehensive, multidisciplinary, educational program on the use of antibiotics in a geriatric university hospital. J Am Geriatr Soc (2004) 0.87
Obesity hypoventilation syndrome: an underdiagnosed and undertreated condition. Am J Respir Crit Care Med (2012) 0.87
Early life T cell responses to pneumococcal conjugates increase with age and determine the polysaccharide-specific antibody response and protective efficacy. Eur J Immunol (2006) 0.87
Seroprevalence of Bordetella pertussis antibodies in Flanders (Belgium). Vaccine (2003) 0.86
Multimodal nutritional rehabilitation improves clinical outcomes of malnourished patients with chronic respiratory failure: a randomised controlled trial. Thorax (2011) 0.86
Partial activation of neonatal CD11c+ dendritic cells and induction of adult-like CD8+ cytotoxic T cell responses by synthetic microspheres. J Immunol (2004) 0.86
Elevated inflammatory markers combined with positive pneumococcal urinary antigen are a good predictor of pneumococcal community-acquired pneumonia in children. Pediatr Infect Dis J (2013) 0.85
Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients. Haematologica (2011) 0.85
Protracted course of lymphocytic choriomeningitis virus WE infection in early life: induction but limited expansion of CD8+ effector T cells and absence of memory CD8+ T cells. J Virol (2007) 0.85
Successful induction of CD8 T cell-dependent protection against malaria by sequential immunization with DNA and recombinant poxvirus of neonatal mice born to immune mothers. J Immunol (2003) 0.85
Tumor necrosis factor neutralization combined with chemotherapy enhances Mycobacterium tuberculosis clearance and reduces lung pathology. Am J Clin Exp Immunol (2013) 0.85
Enhanced pulmonary immunopathology following neonatal priming with formalin-inactivated respiratory syncytial virus but not with the BBG2NA vaccine candidate. Vaccine (2003) 0.84
Early appearance of bactericidal antibodies after polysaccharide challenge of toddlers primed with a group C meningococcal conjugate vaccine: what is its role in the maintenance of protection? Clin Vaccine Immunol (2006) 0.84
Proximal splenic artery embolization for blunt splenic injury: clinical, immunologic, and ultrasound-Doppler follow-up. J Trauma (2007) 0.84
Determinants of vaccine immunity in the cohort of human immunodeficiency virus-infected children living in Switzerland. Pediatr Infect Dis J (2009) 0.83
Safety of DTaP-based combined immunization in very-low-birth-weight premature infants: frequent but mostly benign cardiorespiratory events. J Pediatr (2004) 0.83
Safety and immunogenicity of rts,s+trap malaria vaccine, formulated in the as02a adjuvant system, in infant rhesus monkeys. Am J Trop Med Hyg (2004) 0.83
Generation of adult-like antibody avidity profiles after early-life immunization with protein vaccines. Eur J Immunol (2002) 0.83
Pulmonary cement embolism after vertebroplasty. Thromb Haemost (2006) 0.82
Comparison of airway resistance measurements by the forced oscillation technique and the interrupter technique for detecting chronic obstructive pulmonary disease in elderly patients. Chin Med J (Engl) (2005) 0.82
Perception of chronic respiratory impairment in patients' drawings. J Rehabil Med (2013) 0.82
Pulmonary Disease due to Mycobacterium tuberculosis in a Horse: Zoonotic Concerns and Limitations of Antemortem Testing. Vet Med Int (2012) 0.81
Memory B cell compartment constitution and susceptibility to recurrent lower respiratory tract infections in young children. J Leukoc Biol (2013) 0.81
Blame vaccine interference, not neonatal immunization, for suboptimal responses after neonatal diphtheria, tetanus, and acellular pertussis immunization. J Pediatr (2008) 0.81
Atorvastatin treatment and vaccination efficacy. J Clin Pharmacol (2007) 0.81
Recurrence of cardiorespiratory events following repeat DTaP-based combined immunization in very low birth weight premature infants. J Pediatr (2008) 0.81
Chickenpox in a Swiss prison: susceptibility, post-exposure vaccination and control measures. Scand J Infect Dis (2010) 0.81
A prospective study of the factors shaping antibody responses to the AS03-adjuvanted influenza A/H1N1 vaccine in cancer outpatients. Oncologist (2012) 0.81
Encephalitis associated with glutamic acid decarboxylase autoantibodies in a child: a treatable condition? Arch Neurol (2011) 0.81